249 related articles for article (PubMed ID: 37721138)
1. Histone mutations in cancer.
Espinoza Pereira KN; Shan J; Licht JD; Bennett RL
Biochem Soc Trans; 2023 Oct; 51(5):1749-1763. PubMed ID: 37721138
[TBL] [Abstract][Full Text] [Related]
2. The expanding landscape of 'oncohistone' mutations in human cancers.
Nacev BA; Feng L; Bagert JD; Lemiesz AE; Gao J; Soshnev AA; Kundra R; Schultz N; Muir TW; Allis CD
Nature; 2019 Mar; 567(7749):473-478. PubMed ID: 30894748
[TBL] [Abstract][Full Text] [Related]
3. The dark side of histones: genomic organization and role of oncohistones in cancer.
Amatori S; Tavolaro S; Gambardella S; Fanelli M
Clin Epigenetics; 2021 Apr; 13(1):71. PubMed ID: 33827674
[TBL] [Abstract][Full Text] [Related]
4. A Mutation in Histone H2B Represents a New Class of Oncogenic Driver.
Bennett RL; Bele A; Small EC; Will CM; Nabet B; Oyer JA; Huang X; Ghosh RP; Grzybowski AT; Yu T; Zhang Q; Riva A; Lele TP; Schatz GC; Kelleher NL; Ruthenburg AJ; Liphardt J; Licht JD
Cancer Discov; 2019 Oct; 9(10):1438-1451. PubMed ID: 31337617
[TBL] [Abstract][Full Text] [Related]
5. Cancer-associated mutations of histones H2B, H3.1 and H2A.Z.1 affect the structure and stability of the nucleosome.
Arimura Y; Ikura M; Fujita R; Noda M; Kobayashi W; Horikoshi N; Sun J; Shi L; Kusakabe M; Harata M; Ohkawa Y; Tashiro S; Kimura H; Ikura T; Kurumizaka H
Nucleic Acids Res; 2018 Nov; 46(19):10007-10018. PubMed ID: 30053102
[TBL] [Abstract][Full Text] [Related]
6. Oncohistones: drivers of pediatric cancers.
Mohammad F; Helin K
Genes Dev; 2017 Dec; 31(23-24):2313-2324. PubMed ID: 29352018
[TBL] [Abstract][Full Text] [Related]
7. Histone deposition pathways determine the chromatin landscapes of H3.1 and H3.3 K27M oncohistones.
Sarthy JF; Meers MP; Janssens DH; Henikoff JG; Feldman H; Paddison PJ; Lockwood CM; Vitanza NA; Olson JM; Ahmad K; Henikoff S
Elife; 2020 Sep; 9():. PubMed ID: 32902381
[TBL] [Abstract][Full Text] [Related]
8. H3-K27M-mutant nucleosomes interact with MLL1 to shape the glioma epigenetic landscape.
Furth N; Algranati D; Dassa B; Beresh O; Fedyuk V; Morris N; Kasper LH; Jones D; Monje M; Baker SJ; Shema E
Cell Rep; 2022 May; 39(7):110836. PubMed ID: 35584667
[TBL] [Abstract][Full Text] [Related]
9. Histone H3 mutations--a special role for H3.3 in tumorigenesis?
Kallappagoudar S; Yadav RK; Lowe BR; Partridge JF
Chromosoma; 2015 Jun; 124(2):177-89. PubMed ID: 25773741
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of cancer: Oncohistones in action.
Qiu L; Hu X; Jing Q; Zeng X; Chan KM; Han J
J Genet Genomics; 2018 May; 45(5):227-236. PubMed ID: 29804713
[TBL] [Abstract][Full Text] [Related]
11. Histone H2B Mutations in Cancer.
Wan YCE; Chan KM
Biomedicines; 2021 Jun; 9(6):. PubMed ID: 34205231
[TBL] [Abstract][Full Text] [Related]
12. DNA Repair in Nucleosomes: Insights from Histone Modifications and Mutants.
Selvam K; Wyrick JJ; Parra MA
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673978
[TBL] [Abstract][Full Text] [Related]
13. Oncohistones: a roadmap to stalled development.
Deshmukh S; Ptack A; Krug B; Jabado N
FEBS J; 2022 Mar; 289(5):1315-1328. PubMed ID: 33969633
[TBL] [Abstract][Full Text] [Related]
14. Histone H3K27M Mutation in Brain Tumors.
El-Hashash AHK
Adv Exp Med Biol; 2021; 1283():43-52. PubMed ID: 33155136
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of histone H3-H4 chaperone pathways rescues C. elegans sterility by H2B loss.
Zhao R; Zhu Z; Geng R; Jiang X; Li W; Ou G
PLoS Genet; 2022 Jun; 18(6):e1010223. PubMed ID: 35679337
[TBL] [Abstract][Full Text] [Related]
16. Rpp29 regulates histone H3.3 chromatin assembly through transcriptional mechanisms.
Shastrula PK; Lund PJ; Garcia BA; Janicki SM
J Biol Chem; 2018 Aug; 293(32):12360-12377. PubMed ID: 29921582
[TBL] [Abstract][Full Text] [Related]
17. Regulation of chromatin structure via histone post-translational modification and the link to carcinogenesis.
Thompson LL; Guppy BJ; Sawchuk L; Davie JR; McManus KJ
Cancer Metastasis Rev; 2013 Dec; 32(3-4):363-76. PubMed ID: 23609752
[TBL] [Abstract][Full Text] [Related]
18. Histone H3.3 mutations: a variant path to cancer.
Yuen BT; Knoepfler PS
Cancer Cell; 2013 Nov; 24(5):567-74. PubMed ID: 24229707
[TBL] [Abstract][Full Text] [Related]
19. Chromatin structure related to oncogenesis.
Matsumoto S; Horikoshi N; Takizawa Y; Kurumizaka H
Cancer Sci; 2023 Aug; 114(8):3068-3075. PubMed ID: 37218420
[TBL] [Abstract][Full Text] [Related]
20. Probing the Function of Oncohistones Using Mutant Transgenes and Knock-In Mutations.
Fang D; Wang H; Zhang Z
Methods Mol Biol; 2018; 1832():339-356. PubMed ID: 30073537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
